Mark Elliott is a seasoned in vitro pharmacologist and neuroscientist with 15 years of experience in the biotechnology and pharmaceutical sectors. Currently serving as a Principal Scientist at Lundbeck, Mark leads the Functional & Cellular Pharmacology group in neuroscience. Previously, they held various roles including Senior Principal Scientist and Research Project Leader at Ipsen, where they spearheaded drug discovery projects and cultivated research collaborations. Mark's educational background includes a PhD in Neuropharmacology and a Master's in Molecular Pharmacology from the University of Manchester, as well as a Bachelor’s in Pharmacology from the University of Dundee.
This person is not in the org chart
This person is not in any teams
This person is not in any offices